Self-controlled Study Between 4-hour and 24-hour Delayed Radiographs in HSG Using OSCM

Sponsor
Women's Hospital School Of Medicine Zhejiang University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04744610
Collaborator
Jiangsu Hengrui Pharmaceutical Co., Ltd. (Industry)
80
1
1
4.3
18.7

Study Details

Study Description

Brief Summary

Background of the study:

Hysterosalpingography (HSG) is widely used for the female infertility workup. Many studies have demonstrated that the use of oil-soluble contrast medium (OSCM) ethiodized oil for HSG surgery can improve pregnancy rates. However,The 24-hour delayed radiographs of OSCM HSG also brought some inconvenience to the patients , for example, patients need to make two trips to the hospital.

Objective of the study:

The purpose of this study was to compare OSCM HSGs using 4-hour and 24-hour delayed radiographs in terms of diagnosing tubal patency and identifying the presence of pelvic adhesions.

Study design:

Prospective, open label, self - controlled study

Study population:

Infertile patients scheduled for an OSCM HSG

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Add 4-hour delayed radiographs
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Prospective Self-controlled Study for Shortening the Time Before Taking Delayed Radiographs With Iodized Oil Hysterosalpingography
Actual Study Start Date :
Oct 22, 2020
Anticipated Primary Completion Date :
Feb 1, 2021
Anticipated Study Completion Date :
Mar 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Other: 4-hour delayed radiographs

The follow-up radiographs was taken 4 h after the HSG operation.

Diagnostic Test: Add 4-hour delayed radiographs
Normal patients only need to take delayed radiographs 24h after HSG operation. In this study, 4-hour delayed radiographs were added to the 24-hour delayed radiographs, so that the patients had to take one more delayed radiographs .

Outcome Measures

Primary Outcome Measures

  1. Difference in diagnosis of fallopian tube patency between 4 hours delayed radiographs and 24 hours delayed radiographs. [The evaluation was performed within 1 day after completion of the 24 hours delayed radiographs.]

    The diagnostic results of 4 hours delayed radiographs and 24 hours delayed radiographs were evaluated by two radiologists with more than 5 years' working experience. In case of any dispute, the two doctors reached an agreement after discussion. The results were defined as : completely consistent; mostly consistent;partly consistent;completely different.

Secondary Outcome Measures

  1. Difference in the diagnosis of patency of proximal fallopian tube between 4 hours delayed radiographs and 24 hours delayed radiographs [The evaluation was performed within 1 day after completion of the 24 hours delayed radiographs.]

    The diagnostic results of 4 hours delayed radiographs and 24 hours delayed radiographs were evaluated by two radiologists with more than 5 years' working experience. In case of any dispute, the two doctors reached an agreement after discussion. The results were defined as : completely consistent; mostly consistent;partly consistent;completely different.

  2. Difference in the diagnosis of patency of distal fallopian tube between 4 hours delayed radiographs and 24 hours delayed radiographs [The evaluation was performed within 1 day after completion of the 24 hours delayed radiographs.]

    The diagnostic results of 4 hours delayed radiographs and 24 hours delayed radiographs were evaluated by two radiologists with more than 5 years' working experience. In case of any dispute, the two doctors reached an agreement after discussion. The results were defined as : completely consistent; mostly consistent;partly consistent;completely different.

  3. Difference in the diagnosis of pelvic lesions between 4 hours delayed radiographs and 24 hours delayed radiographs. [The evaluation was performed within 1 day after completion of the 24 hours delayed radiographs.]

    The diagnostic results of 4 hours delayed radiographs and 24 hours delayed radiographs were evaluated by two radiologists with more than 5 years' working experience. In case of any dispute, the two doctors reached an agreement after discussion. The results were defined as : completely consistent; mostly consistent;partly consistent;completely different.

Other Outcome Measures

  1. The incidence of adverse events and serious adverse events. [Within one month after hysterosalpingography procedure.]

    Adverse event levels were assessed according to CTCAE 5.0.

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 38 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Having spontaneous ovulation or inducing ovulation;

  • Infertility lasting for 12 months;

  • Conforms to the indications of hysterosalpingography;

  • Understand and sign the informed consent;

Exclusion Criteria:
  • Iodine allergy or hyperthyroidism

  • Acute genital tract inflammation or abnormal leucorrhea examination;

  • Abnormal vaginal bleeding;

  • Fever or preoperative temperature higher than 37.5℃ within 3 days before angiography;

  • Severe insufficiency of cardiopulmonary or liver function;

  • During pregnancy and menstruation;

  • With complications that may cause subjects to be unable to follow the study plan or even endanger the patient's safety or social environment;

  • Patients who are participating in other clinical studies or who are not suitable for inclusion in this study due to other reasons considered by the researchers.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Women's Hospital, School of Medicine, Zhejiang University Hangzhou Zhejiang China

Sponsors and Collaborators

  • Women's Hospital School Of Medicine Zhejiang University
  • Jiangsu Hengrui Pharmaceutical Co., Ltd.

Investigators

  • Study Chair: Yimin Zhu, Women's Hospital School Of Medicine Zhejiang University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Women's Hospital School Of Medicine Zhejiang University
ClinicalTrials.gov Identifier:
NCT04744610
Other Study ID Numbers:
  • IRB-20200261-R
First Posted:
Feb 9, 2021
Last Update Posted:
Feb 9, 2021
Last Verified:
Jan 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Women's Hospital School Of Medicine Zhejiang University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 9, 2021